24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Molecular and biochemical basis <strong>of</strong> disease<br />

P06.156<br />

increasing power <strong>of</strong> variance component linkage analysis <strong>of</strong><br />

large pedigrees<br />

T. I. Axenovich, I. V. Zorkoltseva, G. R. Svischeva;<br />

Institute <strong>of</strong> Cytology and <strong>Genetics</strong>, Novosibirsk, Russian Federation.<br />

Most methods <strong>of</strong> linkage analysis <strong>of</strong> quantitative traits are based on<br />

the variance component approach . IBD calculation is the most computationally<br />

intensive step <strong>of</strong> this approach . The size <strong>of</strong> IBD matrix for<br />

large pedigrees and especially for those coming from isolated populations<br />

is too large for practical calculation . To solve this problem a<br />

pedigree is split on smaller non-overlapping fragments and then the<br />

fragments are analyzed as independent pedigrees . The split leads to<br />

increase the number <strong>of</strong> IBD matrix elements with zero values . This in<br />

turn decreases the linkage power . To diminish this effect we suggested<br />

to increase the number <strong>of</strong> non zero elements <strong>of</strong> IBD matrix by additional<br />

alternative splitting <strong>of</strong> the pedigree, for example, on overlapping<br />

fragments . Using the pedigree with 207 members in 6 generations, we<br />

estimated the expected linkage power when IBDs were calculated for<br />

a) pairs <strong>of</strong> genotyped members <strong>of</strong> each non-overlapping fragments <strong>of</strong><br />

size no more than 18 bit and b) for (a) plus additional pairs <strong>of</strong> genotyped<br />

relatives from overlapping fragments <strong>of</strong> size no more than 18 bit .<br />

The results demonstrated the effectiveness <strong>of</strong> our method: the power<br />

for variant (b) based on 964 IBDs was 1 .2 - 1 .7 times greater than for<br />

variant (a) based on 844 IBDs . Such once calculated IBD matrix can<br />

further be utilized by various programs (for example, SOLAR) for linkage<br />

analysis <strong>of</strong> different traits .<br />

P06.157<br />

A genome-wide association analysis <strong>of</strong> HDL-cholesterol in the<br />

population-based KORA study sheds new light on intergenic<br />

regions<br />

I. M. Heid 1,2 , E. Boes 3 , M. Mueller 1,2 , B. Kollerits 3 , C. Lamina 1 , S. Coassin 3 , C.<br />

Gieger 1,2 , A. Doering 1 , N. Klopp 1 , R. Frikke-Schmidt 4 , A. Tybjærg-Hansen 4 , A.<br />

Brandstätter 3 , T. Meitinger 1 , H. Wichmann 1,2 , F. Kronenberg 3 ;<br />

1 Helmholtz Zentrum München, Neuherberg, Germany, 2 Ludwig-Maximilians-<br />

University <strong>of</strong> Munich, Munich, Germany, 3 Innsbruck Medical University, Innsbruck,<br />

Austria, 4 Copenhagen University Hospital, Copenhagen, Denmark.<br />

Objective: High-density lipoprotein cholesterol (HDLC) is a strong<br />

risk factor for atherosclerosis and assumed to be under considerable<br />

genetic control. We aimed to identify gene regions influencing HDLC<br />

levels by a genome-wide association (GWA) analysis in the population-based<br />

KORA Study .<br />

Methods: In KORA S3/F3 (n=1,643), we analyzed the 377,865 qualitychecked<br />

single nucleotide polymorphisms (SNPs) <strong>of</strong> the 500K Affymetrix<br />

SNP array, complemented by the publicly available GWA results<br />

from the Diabetes <strong>Genetics</strong> Initiative (DGI, n=2,631) and by replication<br />

studies in KORA S4 (n=4,037) and the Copenhagen City Heart Study<br />

(n=9,205) .<br />

Results: Among the 13 SNPs selected from the KORA S3/F3 500K pvalue<br />

list, three SNPs showed consistent associations in subsequent<br />

replications: two from so far unreported regions 50 kb downstream <strong>of</strong><br />

LIPG or upstream <strong>of</strong> CETP and one from already reported regions <strong>of</strong><br />

the LPL . The SNP in CETP and several SNPs downstream <strong>of</strong> LIPG<br />

were independent from already reported SNPs and might be <strong>of</strong> functional<br />

relevance . The other 10 as well as further 13 SNPs selected<br />

from the combined GWA p-value list <strong>of</strong> KORA S3/F3 and DGI failed<br />

consistent replication .<br />

Conclusions: Our GWA study identified two new HDLC-relevant regions,<br />

which generally motivates to extend the focus <strong>of</strong> future genetic<br />

association studies on long-range effects <strong>of</strong> intergenic regions . Furthermore,<br />

our study reinforced CETP and LPL as strong HDLC genes<br />

and thereby underscores the power <strong>of</strong> our study and <strong>of</strong> the GWA approach<br />

in general to pinpoint strong effects from common polymorphisms<br />

.<br />

P06.158<br />

Genetic variants in the UsF1 gene are not associated with mets,<br />

T2DM, and related parameters in Caucasians (KORA study)<br />

N. Klopp 1 , C. Holzapfel 1 , H. Grallert 1 , C. Huth 1 , C. Gieger 1 , C. Meisinger 1 , K.<br />

Strassburger 2 , G. Giani 2 , H. Wichmann 1 , C. Herder 2 , W. Rathmann 2 , T. Illig 1 ;<br />

1 Helmholtz Zentrum München, Munich-Neuherberg, Germany, 2 German Diabe-<br />

tes Center, Leibniz Institute at Heinrich-Heine-University, Düsseldorf, Germany.<br />

Upstream stimulatory factor 1 (USF1) regulates numerous genes <strong>of</strong><br />

glucose and lipid metabolism and genetic variants in the USF1 gene<br />

show association with familial combined hyperlipidemia, which shows<br />

phenotypic overlap with the metabolic syndrome (MetS) and type 2<br />

diabetes mellitus (T2DM) . The aim <strong>of</strong> our study was to approve the<br />

hypothesis that polymorphisms in the USF1 gene are associated with<br />

MetS and related metabolic traits . We genotyped eight single nucleotide<br />

polymorphisms in the USF1 gene in 1,653 individuals <strong>of</strong> the<br />

population-based German Caucasian KORA study in the age range<br />

between 55 and 74 years . Because <strong>of</strong> high correlation only six polymorphisms<br />

were statistically analyzed . The association with T2DM and<br />

the MetS was analyzed by logistic regression in 1,462 subjects and the<br />

quantitative parameters were analyzed in 1,231 fasting non diabetic<br />

subjects by linear regression respectively by Kruskal-Wallis test . None<br />

<strong>of</strong> the analyzed genetic variants (rs2774279, rs10908821, rs1556259,<br />

rs2516839, rs3737787, rs2774276) show significant association with<br />

T2DM and MetS . The results for the metabolic traits like triglycerides,<br />

total cholesterol, HDL cholesterol, LDL cholesterol, percent body fat,<br />

waist to hip ratio, ureic acid, fasting glucose, 2 hour plasma glucose,<br />

fasting insulin, blood pressure give also no evidence for any association<br />

with USF1 . In our large population based study no association between<br />

single genetic variants in the USF1 gene and T2DM, MetS and<br />

related metabolic parameters was found . We conclude that the single<br />

genetic variants in USF1 have no major effect on lipid and glucose<br />

parameters in German Caucasians .<br />

P06.159<br />

Genome-wide linkage analysis for identifying quantitative trait<br />

loci involved in the regulation <strong>of</strong> lipoprotein a (lpa) levels<br />

S. Lopez 1 , A. Buil 1,2 , J. Ordoñez 3,4 , J. C. Souto 1 , L. Almasy 5 , M. Lathrop 6 , J.<br />

Blangero 5 , F. Blanco-Vaca 3,7 , J. Fontcuberta 1 , J. M. Soria 1,2 ;<br />

1 Haemostasis and Thrombosis Unit, Department <strong>of</strong> Hematology, Hospital de la<br />

Santa Creu i Sant Pau, <strong>Barcelona</strong>, Spain, 2 Bioinformatic <strong>of</strong> Complex Diseases<br />

Unit. Research Institute <strong>of</strong> Hospital de la Santa Creu i Sant Pau, <strong>Barcelona</strong>,<br />

Spain, 3 Department <strong>of</strong> Biochemistry. Hospital de la Santa Creu i Sant Pau, <strong>Barcelona</strong>,<br />

Spain, 4 Department <strong>of</strong> Biochemistry and Molecular Biology. Universitat<br />

Autònoma de <strong>Barcelona</strong>, <strong>Barcelona</strong>, Spain, 5 Department <strong>of</strong> Population <strong>Genetics</strong>.<br />

Southwest Foundation for Biomedical Research, San Antonio, TX, United<br />

States, 6 Centre National du Genotypage, Paris, France, 7 CIBER de Diabetes y<br />

Enfermedades Metabólicas Asociadas, <strong>Barcelona</strong>, Spain.<br />

Lipoprotein Lp(a) levels are highly heritable and are associated with<br />

cardiovascular risk . We performed a genome-wide linkage analysis<br />

to delineate the genomic regions that influence the concentration <strong>of</strong><br />

Lp(a) in families from the Genetic Analysis <strong>of</strong> Idiopathic Thrombophilia<br />

(GAIT) Project . Lp(a) levels were measured in 387 individuals belonging<br />

to 21 extended Spanish families . A total <strong>of</strong> 485 DNA microsatellite<br />

markers were genotyped to provide a 7 .1 cM genetic map . A variance<br />

component linkage method was used to evaluate linkage and to detect<br />

quantitative trait loci (QTLs) . The main QTL that showed strong evidence<br />

<strong>of</strong> linkage with Lp(a) levels was located at the structural gene<br />

for apo(a) on Chromosome 6 (LOD score=13 .8) . Interestingly, another<br />

QTL influencing Lp(a) concentration was located on Chromosome<br />

2 with a LOD score <strong>of</strong> 2 .01 . This region contains several candidate<br />

genes . One <strong>of</strong> them is the tissue factor pathway inhibitor (TFPI), which<br />

has antithrombotic action and also has the ability to bind lipoproteins .<br />

However, quantitative trait association analyses performed with 12<br />

SNPs in TFPI gene revealed no association with Lp(a) levels . Our<br />

study confirms previous results on the genetic basis <strong>of</strong> Lp(a) levels.<br />

In addition, we report a new QTL on Chromosome 2 involved in the<br />

quantitative variation <strong>of</strong> Lp(a) . These data should serve as the basis<br />

for further detection <strong>of</strong> candidate genes and to elucidate the relationship<br />

between the concentration <strong>of</strong> Lp(a) and cardiovascular risk .<br />

P06.160<br />

Identification <strong>of</strong> a novel autosomal recessive locus on<br />

chromosome 5q31-34 for the long Qt syndrome<br />

Z. N. Al-Hassnan, S. Majid, M. Al-Fayyadh, N. Dzimiri, Y. Mallawi, W. Al Manea,<br />

M. Al-Owain, B. Meyer;<br />

King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.<br />

It is estimated that a significant percentage <strong>of</strong> sudden deaths are due<br />

to the long QT syndrome (LQTS) which is an inherited arrhythmogenic<br />

disorder that is characterized by locus heterogeneity . Mutations in

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!